These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11474812)

  • 1. Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors.
    Yenari MA; Dumas TC; Sapolsky RM; Steinberg GK
    Neurol Res; 2001 Jul; 23(5):543-52. PubMed ID: 11474812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors.
    Yenari MA; Dumas TC; Sapolsky RM; Steinberg GK
    Ann N Y Acad Sci; 2001 Jun; 939():340-57. PubMed ID: 11462790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy and hypothermia for stroke treatment.
    Yenari MA; Zhao H; Giffard RG; Sobel RA; Sapolsky RM; Steinberg GK
    Ann N Y Acad Sci; 2003 May; 993():54-68; discussion 79-81. PubMed ID: 12853295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke.
    Lawrence MS; McLaughlin JR; Sun GH; Ho DY; McIntosh L; Kunis DM; Sapolsky RM; Steinberg GK
    J Cereb Blood Flow Metab; 1997 Jul; 17(7):740-4. PubMed ID: 9270490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated Bcl-X(L) expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice.
    Kilic E; Hermann DM; Kügler S; Kilic U; Holzmüller H; Schmeer C; Bähr M
    Neurobiol Dis; 2002 Nov; 11(2):275-84. PubMed ID: 12505420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy using viral vectors for acute neurologic insults.
    Sapolsky RM; Steinberg GK
    Neurology; 1999 Dec; 53(9):1922-31. PubMed ID: 10599759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection with herpes simplex vectors expressing virally derived anti-apoptotic agents.
    Roy M; Hom J; Sapolsky RM
    Brain Res; 2001 May; 901(1-2):12-22. PubMed ID: 11368945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
    Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
    Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy in neurological disease.
    Yenari MA; Sapolsky RM
    Methods Mol Med; 2005; 104():75-88. PubMed ID: 15454665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of gene therapy: potential applications in the treatment of cerebral ischaemia.
    Papadopoulos MC; Giffard RG; Bell BA
    Br J Neurosurg; 2000 Oct; 14(5):407-14. PubMed ID: 11198761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of cerebral ischemia-induced neuronal death.
    Hou ST; MacManus JP
    Int Rev Cytol; 2002; 221():93-148. PubMed ID: 12455747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage.
    Hoehn B; Ringer TM; Xu L; Giffard RG; Sapolsky RM; Steinberg GK; Yenari MA
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1303-9. PubMed ID: 11702045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect.
    Natsume A; Mata M; Wolfe D; Oligino T; Goss J; Huang S; Glorioso J; Fink DJ
    J Neurotrauma; 2002 Jan; 19(1):61-8. PubMed ID: 11852979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective potential of a viral vector system induced by a neurological insult.
    Ozawa CR; Ho JJ; Tsai DJ; Ho DY; Sapolsky RM
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9270-5. PubMed ID: 10908682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion.
    Yamada M; Natsume A; Mata M; Oligino T; Goss J; Glorioso J; Fink DJ
    Exp Neurol; 2001 Apr; 168(2):225-30. PubMed ID: 11259110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy.
    Yenari MA; Fink SL; Sun GH; Chang LK; Patel MK; Kunis DM; Onley D; Ho DY; Sapolsky RM; Steinberg GK
    Ann Neurol; 1998 Oct; 44(4):584-91. PubMed ID: 9778256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke.
    Lawrence MS; Sun GH; Kunis DM; Saydam TC; Dash R; Ho DY; Sapolsky RM; Steinberg GK
    J Cereb Blood Flow Metab; 1996 Mar; 16(2):181-5. PubMed ID: 8594048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression in cerebral ischemia: a new approach for neuroprotection.
    Millán M; Arenillas J
    Cerebrovasc Dis; 2006; 21 Suppl 2():30-7. PubMed ID: 16651812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia.
    Antonawich FJ; Federoff HJ; Davis JN
    Exp Neurol; 1999 Mar; 156(1):130-7. PubMed ID: 10192784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage.
    Tsai TH; Chen SL; Chiang YH; Lin SZ; Ma HI; Kuo SW; Tsao YP
    Exp Neurol; 2000 Dec; 166(2):266-75. PubMed ID: 11085892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.